0000950170-23-031637.txt : 20230705 0000950170-23-031637.hdr.sgml : 20230705 20230705161945 ACCESSION NUMBER: 0000950170-23-031637 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230701 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alleva Lawrence M CENTRAL INDEX KEY: 0001553053 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 231069296 MAIL ADDRESS: STREET 1: 1000 WINTER STREET STREET 2: SUITE 3300 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 4 1 ownership.xml 4 X0407 4 2023-07-01 0001563577 Galera Therapeutics, Inc. GRTX 0001553053 Alleva Lawrence M C/O GALERA THERAPEUTICS, INC., 45 LIBERTY BLVD #230 MALVERN PA 19355 true false false false false Stock Option (Right to Buy) 3.12 2023-07-01 4 A false 22762 0 A 2033-06-30 Common Stock 22762 22762 D This option was awarded pursuant to the "elective option" provisions of the Issuer's non-employee director compensation program for the Reporting Person's service on the Issuer's Board and certain of its committees. This option shall vest and become exercisable as to 25% of the shares subject to the option upon the Reporting Person completing each three months of continuous service as a Non-Employee Director, or in the applicable committee position, following the date of grant, provided that the fourth and final tranche of the option will vest and become exercisable on the earlier of July 1, 2024 or the day immediately prior to the date of the Issuer's next annual meeting of stockholders occurring after the date of grant, in either case subject to the Reporting Person continuing in service on the Board as a Non-Employee Director, or in the applicable committee position, through such vesting date. /s/ Christopher Degnan, Attorney-in-Fact for Lawrence M. Alleva 2023-07-05